Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Inventory (2016 - 2025)

Arcadia Biosciences filings provide 12 years of Inventory readings, the most recent being $1.2 million for Q4 2025.

  • On a quarterly basis, Inventory rose 34.07% to $1.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.2 million, a 34.07% increase, with the full-year FY2025 number at $1.2 million, up 34.07% from a year prior.
  • Inventory hit $1.2 million in Q4 2025 for Arcadia Biosciences, down from $1.5 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $5.4 million in Q3 2021 to a low of $835000.0 in Q3 2024.
  • Median Inventory over the past 5 years was $2.5 million (2022), compared with a mean of $2.4 million.
  • Biggest five-year swings in Inventory: surged 200.75% in 2021 and later tumbled 69.09% in 2024.
  • Arcadia Biosciences' Inventory stood at $4.4 million in 2021, then crashed by 47.64% to $2.3 million in 2022, then plummeted by 63.94% to $837000.0 in 2023, then rose by 8.0% to $904000.0 in 2024, then soared by 34.07% to $1.2 million in 2025.
  • The last three reported values for Inventory were $1.2 million (Q4 2025), $1.5 million (Q3 2025), and $1.5 million (Q2 2025) per Business Quant data.